Earnings Call · Q3 FY2024·2024-11-07

Q3 24EPS +100.00%*·Rev n/aQ2 24EPS +0.60%·Rev n/aQ1 24EPS +14.01%·Rev n/aQ4 23EPS +100.00%*·Rev n/a⚠ consensus missing

Moderna, Inc. MRNA

Lavina Talukdar — Head of Investor Relations

Stéphane Bancel — Chief Executive Officer

Jamey Mock — Chief Financial Officer

Stephen Hoge — President

−3.0%1d on move date−3.7% vs SPY3d−17.5%5d−18.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRNA calls or request research access.

More MRNA calls Browse calls Request research access